Report finds FDA doing a better job monitoring drugs once they go to market
The FDA has made strides in improving its oversight of drugs after they are approved for consumers. The drug recall lawyers of Elk & Elk want you to know about the steps taken to keep your drugs safe.
The U.S. Food and Drug Administration often takes a lot of flak for failing to monitor drugs once they have gone to market. In answer to that criticism, the agency’s Center for Drug Evaluation and Research released a report over the weekend detailing the improvements the organization has made in that area.
“Advances in FDA’s Safety Program for Marketed Drugs” describes how a strengthened and modernized postmodern drug safety program has substantially improved the FDA’s oversight of drugs after they reach consumers. New scientific tools and enhanced capabilities have allowed the FDA to give the same priority to postmarket drug safety monitoring as it does to premarket drug review. (more…)
